Abstract

Melanogenesis plays an important role in the protection of skin against UV through production of melanin pigments, but abnormal accumulation of this pigment causes unaesthetic hyperpigmentation. Much effort is being made to develop effective depigmenting agents. Here, we show for the first time that a small library of mimosine dipeptide enantiomers (Mi-l/d-amino acid) inhibit the melanogenesis in B16F10 melanoma cells by down-regulating the cellular tyrosinase with little effect on their growth or viability. Two of them, Mi-d-Trp and Mi-d-Val, turned out to be the most potent inhibitors on melanin content and cellular tyrosinase in B16F10 melanoma cells. In addition, most of the mimosine dipeptides were more potent than mimosine for inhibiting cyclooxygenase 1 (COX-1) with IC50 of 18–26 μM. Among them, Mi-l-Val and Mi-l-Trp inhibited cyclooxygenase 2 (COX-2) more potently than indomethacin, with IC50 values of 22 and 19 μM, respectively. Taken together, our results suggest the possibility that mimosine dipeptides could be better candidates (than mimosine) for anti-melanogenic (skin hyperpigmentation treatment) and cyclooxygenase (COX) inhibition.

Highlights

  • Melanogenesis is a physiological process that results in the synthesis of melanin pigment and has many functions in living systems [1]

  • Our general strategy for the design of these compounds was based on the conjugation of mimosine and an amino acid through solid-phase synthesis using Fmoc chemistry

  • We showed that a small library of mimosine dipeptides had strong tyrosinase inhibition in vitro

Read more

Summary

Introduction

Melanogenesis is a physiological process that results in the synthesis of melanin pigment and has many functions in living systems [1]. Tyrosinase is a key enzyme in melanogenesis in melanocytes [4]. The inhibition of tyrosinase activity is capitalized for inhibition of melanogenesis and the treatment of skin hyperpigmentation and whitening [2]. The major action of NSAIDs is based on inhibition of cyclooxygenase (COX), which is the rate limiting enzyme in the pathway facilitating the conversion of arachidonic acid to inflammatory prostaglandins [7]. Mimosine [β-[N-(3-hydroxy-4-oxypyridyl)]-α-aminopropionic acid] is a non-protein amino acid containing an alanine side chain bound to the nitrogen atom of a pyridine ring. It is found in several tropical and subtropical plants, which possesses a wide range of biological activities [11,12].

Synthesis and Tyrosinase Inhibition of Mimosine Dipeptides
Inhibition of Melanogenesis by Mimosine Dipeptides
Chemicals and Reagents
Mimosine Isolation from Leucaena leucocephala Leaves
Preparation of Fmoc-Mimosine
General Procedure for Synthesis of Mimosine Dipeptides
Tyrosinase Inhibition Assay
Cell Culture
Cell Viability Assay
Determination of Melanin Content in B16F10 Cells
Intracellular Tyrosinase Inhibition Assay
3.11. Data Analysis
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.